GMO U.S. Value ETF (NYSEARCA:GMOV – Get Free Report) was the recipient of a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 509 shares, a decrease of 90.1% from the July 30th total of 5,166 shares. Based on an average daily volume of 10,463 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.
GMO U.S. Value ETF Stock Up 0.1%
GMOV stock traded up $0.04 during trading on Wednesday, hitting $32.81. 3,674 shares of the company’s stock traded hands, compared to its average volume of 16,014. The firm has a market capitalization of $104.99 million, a P/E ratio of 12.08 and a beta of 0.62. The business has a fifty day simple moving average of $31.18 and a two-hundred day simple moving average of $29.89. GMO U.S. Value ETF has a 1 year low of $25.66 and a 1 year high of $32.88.
Institutional Investors Weigh In On GMO U.S. Value ETF
A number of hedge funds have recently made changes to their positions in the stock. RPS Advisory Solutions LLC acquired a new position in shares of GMO U.S. Value ETF during the fourth quarter worth $484,000. Pathway Financial Advisors LLC purchased a new position in GMO U.S. Value ETF during the 2nd quarter worth $246,000. Fifth Third Bancorp purchased a new position in GMO U.S. Value ETF during the 1st quarter worth $84,000. MML Investors Services LLC acquired a new position in GMO U.S. Value ETF during the 4th quarter valued at about $1,794,000. Finally, StoneX Group Inc. acquired a new position in GMO U.S. Value ETF during the 4th quarter valued at about $1,536,000.
GMO U.S. Value ETF Company Profile
The GMO US Value ETF (GMOV) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, investing primarily in US equity securities. The fund seeks to identify undervalued US stocks using proprietary quantitative methods, capitalizing on perceived market dislocations GMOV was launched on Oct 28, 2024 and is issued by GMO.
Further Reading
- Five stocks we like better than GMO U.S. Value ETF
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for GMO U.S. Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
